Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD)
- PMID: 37989980
- DOI: 10.1007/s12035-023-03775-0
Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD)
Erratum in
-
Correction to: Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD).Mol Neurobiol. 2024 Jun;61(6):3441. doi: 10.1007/s12035-023-03838-2. Mol Neurobiol. 2024. PMID: 38079110 No abstract available.
Abstract
Depression is a complex psychiatric disorder influenced by various genetic and environmental factors. Strong evidence has established the contribution of genetic factors in depression through twin studies and the heritability rate for depression has been reported to be 37%. Genetic studies have identified genetic variations associated with an increased risk of developing depression. Imaging genetics is an integrated approach where imaging measures are combined with genetic information to explore how specific genetic variants contribute to brain abnormalities. Neuroimaging studies allow us to examine both structural and functional abnormalities in individuals with depression. This review has been designed to study the correlation of the significant genetic variants with different regions of neural activity, connectivity, and structural alteration in the brain as detected by imaging techniques to understand the scope of biomarkers in depression. This might help in developing novel therapeutic interventions targeting specific genetic pathways or brain circuits and the underlying pathophysiology of depression based on this integrated approach can be established at length.
Keywords: Depression; Functional magnetic resonance imaging; Genetic polymorphism; Major depressive disorder; Neuroimaging.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392(10159):1789–1858
-
- Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11)
-
- Edition F (2013) Diagnostic and statistical manual of mental disorders. Am Psychiatric Assoc 21(21):591–643
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
